VitaSpring Biomedical Co. Ltd.
VSBC
$1.00
$0.000.00%
OTC PK
| 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | 10/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 4.02% | -152.08% | -70.61% | 1,012.21% | -154.26% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 375.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 200.00% | -127.43% | -71.96% | 3,826.53% | -90.57% |
| Change in Net Operating Assets | -4.45% | 126.99% | 71.99% | -417.87% | -713.31% |
| Cash from Operations | 104.34% | -104.98% | 82.08% | 58.39% | -245.15% |
| Capital Expenditure | -- | -- | -- | 100.00% | 53.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 53.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.34% | -104.98% | 73.69% | 73.30% | -290.66% |